$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
European Commission approves bestivan for treatment of VHL disease-related tumors, advanced ccRCC
2026-02-01 22:25:32
Check Details
If you take 75 mg of dabrafenib/dabrafenib, how many boxes are needed for one course of treatment?
2026-02-01 22:25:32
Check Details
What are the indications for Osimertinib/Tagressa? Which patients are suitable for use?
2026-02-01 22:25:32
Check Details
Is Eltrombopag/Eltrombopag a hormonal drug? This article will clear up your doubts!
2026-02-01 22:25:32
Check Details
What's the matter with my platelet count falling even though I've been taking Ropremilast/Romigrastim?
2026-02-01 22:25:32
Check Details
Axitinib/Axitinib Targeted Drug Instructions: Detailed Usage Guidelines and Precautions
2026-02-01 22:25:32
Check Details
Trametinib manufacturer reveals: drug quality and global supply
2026-02-01 22:25:32
Check Details
Actual costs borne by patients after reimbursement by medical insurance for imatinib/Gleevec
2026-02-01 22:25:32
Check Details
The secret of the Indian version of ruxolitinib/ruxolitinib cream: know the quality and price!
2026-02-01 22:25:32
Check Details
How effective is enzalutamide? What is the efficacy and clinical performance in patients with prostate cancer?
2026-02-01 22:25:32
Check Details
Who is the manufacturer of sorafenib? What is the production and quality control of this drug?
2026-02-01 22:25:32
Check Details
How long can I take fostatinib? How long will the medication be used according to the treatment plan?
2026-02-01 22:25:32
Check Details
1
2
...
1428
1429
1430
1431
1432
1433
1434
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
2
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
3
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
4
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
5
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
6
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
7
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
8
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
9
Filgotinib: Mechanism of Action and Clinical Applications Explained
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide